Adherence to antiretroviral therapy (ART) remains a challenge for many people with HIV and was exacerbated during the COVID-19 pandemic. This paper examines factors associated with ART adherence among people with HIV who inject drugs (PWHWID) in Almaty, Kazakhstan during the COVID-19 pandemic.
Methods
A cross-sectional survey was conducted from October 2020 to August 2022 with 66 PWHWID and their treatment support partners (n = 66) to assess associations between ART adherence and sociodemographic, COVID-19 related, social support, and other factors. Multilevel generalized linear mixed models were used to examine factors associated with optimal (≥90%) and standard (≥80%) adherence levels.
Results
We found low medication adherence rates: only 55.8% took ≥80% of their doses, and just 14.7% took ≥90%. People were more likely to take their medication consistently if they had a partner with HIV, experienced less household conflict during COVID-19, or met with addiction professionals. Poor mental health and negative emotional impacts from COVID-19 were associated with low adherence.
Conclusion
These findings suggest that HIV treatment programs should consider the importance of patients’ relationship factors, mental health, and home environment impacts during public health crises.
LimaVDHarriganRMurrayM, et al.Differential impact of adherence on long-term treatment response among naive HIV-infected individuals. AIDS2008; 22(17): 2371–2380.
2.
BangsbergDRAcostaEPGuptaR, et al.Adherence–resistance relationships for protease and non-nucleoside reverse transcriptase inhibitors explained by virological fitness. AIDS2006; 20(2): 223–231.
3.
FlynnPMRudyBJDouglasSD, et al.Virologic and Immunologic outcomes after 24 Weeks in HIV type 1–infected Adolescents receiving highly active antiretroviral therapy. J Infect Dis2004; 190(2): 271–279.
4.
McNabbJRossJWAbriolaK, et al.Adherence to highly active antiretroviral therapy predicts virologic outcome at an Inner‐City Human Immunodeficiency virus clinic. Clin Infect Dis2001; 33(5): 700–705.
5.
AlgarinABVaras-RodríguezEValdiviaC, et al.Symptoms, stress, and HIV-related care among older people living with HIV during the COVID-19 pandemic, Miami, Florida. AIDS Behav2020; 24(8): 2236–2238.
6.
VasylyevaTISmyrnovPStrathdeeS, et al.Challenges posed by COVID‐19 to people who inject drugs and lessons from other outbreaks. J Int AIDS Soc2020; 23(7): e25583.
The Republican AIDS Center. Estimates of HIV cases, testing, linkage to care, initiation of ART and viral suppression among PWID as of july 1, 2014. Kazakhstan: Almaty, 2014.
9.
WhitfieldMReedHWebsterJ, et al.The impact of COVID-19 restrictions on needle and syringe programme provision and coverage in England. Int J Drug Policy2020; 83: 102851.
10.
European Monitoring Centre for Drugs and Drug Addiction. European Police Office. EU drug markets: impact of COVID 19. [Internet]. LU. Publications Office, 2020. [cited 2024 Jun 9]. Available from: https://data.europa.eu/doi/10.2810/19284
11.
HamadaniJDHasanMIBaldiAJ, et al.Immediate impact of stay-at-home orders to control COVID-19 transmission on socioeconomic conditions, food insecurity, mental health, and intimate partner violence in Bangladeshi women and their families: an interrupted time series. Lancet Glob Health2020; 8(11): e1380–e1389.
12.
GalvezSJAlticeFLMeteliukA, et al.High perceived stress in patients on opioid agonist therapies during rapid transitional response to the COVID-19 pandemic in Ukraine. Front Public Health2023; 11: 1231581.
13.
JoskaJAAndersenLRabieS, et al.COVID-19: increased risk to the mental health and safety of women living with HIV in South Africa. AIDS Behav2020; 24(10): 2751–2753.
14.
DavisAMergenovaGLandersSE, et al.Implementation of a dyad-based intervention to improve antiretroviral therapy adherence among HIV-positive people who inject drugs in Kazakhstan: a randomized trial. Res Soc Work Pract2023; 33(3): 313–324.
15.
WilsonIBLeeYMichaudJ, et al.Validation of a new three-item self-report measure for medication adherence. AIDS Behav2016; 20(11): 2700–2708.
16.
FerroEGWeikumDVagenasP, et al.Alcohol use disorders negatively influence antiretroviral medication adherence among men who have sex with men in Peru. AIDS Care2015; 27(1): 93–104.
17.
AlticeFEvuarherheOShinaS, et al.Adherence to HIV treatment regimens: systematic literature review and meta-analysis. Patient Prefer Adherence2019; 13: 475–490.
18.
PhillipsTBrittainKMellinsCA, et al.A self-reported adherence measure to screen for Elevated HIV viral load in pregnant and postpartum women on antiretroviral therapy. AIDS Behav2017; 21(2): 450–461.
19.
ViswanathanSDetelsRMehtaSH, et al.Level of adherence and HIV RNA suppression in the current Era of highly active antiretroviral therapy (HAART). AIDS Behav2015; 19(4): 601–611.
20.
PatersonDLSwindellsSMohrJ, et al.Adherence to protease Inhibitor therapy and outcomes in patients with HIV infection. Ann Intern Med2000; 133(1): 21–30.
21.
StallRHoffCCoatesTJ, et al.Decisions to Get HIV tested and to Accept antiretroviral therapies among Gay/Bisexual men: Implications for secondary prevention efforts. J Acquir Immune Defic Syndr Hum Retrovirol1996; 11(2): 151–160.
22.
RoohafzaHRamezaniMSadeghiM, et al.Development and validation of the stressful life event questionnaire. Int J Public Health2011; 56(4): 441–448.
23.
KubanyESHaynesSNLeisenMB, et al.Development and preliminary validation of a brief broad-spectrum measure of trauma exposure: the traumatic life events questionnaire. Psychol Assess2000; 12(2): 210–224.
24.
WhettenKReifSSwartzM, et al.A brief mental health and substance Abuse screener for persons with HIV. AIDS Patient Care STDS2005; 19(2): 89–99.
25.
BreuerEStoloffKMyerL, et al.The Validity of the substance Abuse and mental Illness Symptom screener (SAMISS) in people living with HIV/AIDS in primary HIV care in Cape Town, South Africa. AIDS Behav2014; 18(6): 1133–1141.
26.
BreuerEStoloffKMyerL, et al.Reliability of the Lay adherence Counsellor administered substance Abuse and mental Illness Symptoms screener (SAMISS) and the International HIV Dementia scale (IHDS) in a primary care HIV clinic in Cape Town, South Africa. AIDS Behav2012; 16(6): 1464–1471.
27.
BarreraM. A method for the assessment of social support networks in community survey research. Connections1980; 3(3): 8–13.
28.
TardyCH. Social support measurement. American J of Comm Psychol1985; 13(2): 187–202.
McNeishDM. Using data-dependent priors to mitigate small sample bias in latent growth models: a discussion and Illustration using M plus. J Educ Behav Stat2016; 41(1): 27–56.
31.
BursacZGaussCHWilliamsDK, et al.Purposeful selection of variables in logistic regression. Source Code Biol Med2008; 3(1): 17.
32.
BürknerP-C. Brms: An R package for Bayesian multilevel models using Stan. J Stat Soft [Internet]2017; 80(1): 2. [cited 2024 Nov 9] Available from: https://www.jstatsoft.org/v80/i01/
JohnsonMODilworthSETaylorJM, et al.Primary relationships, HIV treatment adherence, and Virologic control. AIDS Behav2012; 16(6): 1511–1521.
35.
JonesDCookRSpenceA, et al.Antiretroviral therapy in Zambia: Do partners on ART enhance adherence?J Int Assoc Provid AIDS Care2014; 13(6): 497–500.
36.
MeylerDStimpsonJPPeekMK. Health concordance within couples: a systematic review. Soc Sci Med2007; 64(11): 2297–2310.
37.
SafrenSAO’CleirighCSkeerMR, et al.Demonstration and evaluation of a peer-delivered, individually-tailored, HIV prevention intervention for HIV-infected MSM in their primary care setting. AIDS Behav2011; 15(5): 949–958.
38.
RemienRHStirrattMJDolezalC, et al.Couple-focused support to improve HIV medication adherence: a randomized controlled trial. AIDS2005; 19(8): 807–814.
39.
HongCQueirozAHoskinJ. The impact of the COVID‐19 pandemic on mental health, associated factors and coping strategies in people living with HIV: a scoping review. J Int AIDS Soc2023; 26(3): e26060.
40.
SaltzmanLYHanselTCBordnickPS. Loneliness, isolation, and social support factors in post-COVID-19 mental health. Psychol Trauma2020; 12(S1): S55–S57.
41.
MergenovaGDavisAGilbertL, et al.Mental health and cognition in relation to adherence to antiretroviral therapy among people living with HIV in Kazakhstan: a cross-sectional study. J Int AIDS Soc2024; 27(Suppl 3): e26320.
